A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Compounded formulations can cost less than half the price of the branded drugs ... “What tirzepatide coming off shortage has taught us is that we need to be better prepared for when semaglutide comes ...

The drugs include Mounjaro, also known as tirzepatide, and semaglutide, which is sold under the brand names ... However, less ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

Ministers have been urged to ditch "gimmicks and soundbites" while addressing the soaring cost of obesity to the NHS.

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy ... He is concerned about the financial costs and health risks potentially posed by these drugs. There is ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...